Covered recipient · General Payments record
ENRIQUE MEDINA ORTIZ
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2022–2024
$3,199.02
- Reported across 98 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,209.82 | 47 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $287.29 | 13 |
| Amgen Inc. | $257.57 | 11 |
| Janssen Biotech, Inc. | $213.40 | 5 |
| Aurinia Pharma U.S., Inc. | $106.60 | 2 |
| Lilly USA, LLC | $87.88 | 4 |
| UCB, Inc. | $52.04 | 2 |
| Radius Health, Inc. | $49.24 | 2 |
| ANI Pharmaceuticals, Inc. | $41.67 | 2 |
| PFIZER INC. | $35.62 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $34.55 | 2 |
| Alexion Pharmaceuticals, Inc. | $24.86 | 1 |
| GlaxoSmithKline, LLC. | $19.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (47)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.63 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105013566 | CMS |
| ABBVIE INC. | $29.27 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105013568 | CMS |
| ABBVIE INC. | $21.88 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105013570 | CMS |
| ABBVIE INC. | $33.42 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105013572 | CMS |
| ABBVIE INC. | $29.47 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105013574 | CMS |
| ABBVIE INC. | $26.04 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105013576 | CMS |
| ABBVIE INC. | $22.22 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105013578 | CMS |
| ABBVIE INC. | $12.73 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105013580 | CMS |
| ABBVIE INC. | $27.44 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105013582 | CMS |
| ABBVIE INC. | $6.30 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105013584 | CMS |
| ABBVIE INC. | $18.28 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105013586 | CMS |
| ABBVIE INC. | $18.50 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105013588 | CMS |
| ABBVIE INC. | $9.11 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105013590 | CMS |
| Alexion Pharmaceuticals, Inc. | $24.86 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094028621 | CMS |
| Amgen Inc. | $20.18 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117325833 | CMS |
| Amgen Inc. | $34.26 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117325831 | CMS |
| Amgen Inc. | $13.54 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117325835 | CMS |
| Amgen Inc. | $13.22 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111649192 | CMS |
| Amgen Inc. | $18.44 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117325837 | CMS |
| Amgen Inc. | $29.53 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111649180 | CMS |
| Amgen Inc. | $22.62 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111649184 | CMS |
| Amgen Inc. | $28.48 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111649186 | CMS |
| Amgen Inc. | $28.24 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111649188 | CMS |
| Amgen Inc. | $20.07 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111649182 | CMS |
| Amgen Inc. | $28.99 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111649190 | CMS |
| ANI Pharmaceuticals, Inc. | $18.80 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091167198 | CMS |
| ANI Pharmaceuticals, Inc. | $22.87 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091132795 | CMS |
| Aurinia Pharma U.S., Inc. | $84.60 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150687313 | CMS |
| Aurinia Pharma U.S., Inc. | $22.00 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150687315 | CMS |
| GlaxoSmithKline, LLC. | $19.10 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116487175 | CMS |
| Janssen Biotech, Inc. | $25.99 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078780073 | CMS |
| Janssen Biotech, Inc. | $122.39 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078780254 | CMS |
| Janssen Biotech, Inc. | $20.56 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078780406 | CMS |
| Janssen Biotech, Inc. | $24.84 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078780178 | CMS |
| Janssen Biotech, Inc. | $19.62 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078779993 | CMS |
| Lilly USA, LLC | $22.17 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136165582 | CMS |
| Lilly USA, LLC | $22.67 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136165584 | CMS |
| Lilly USA, LLC | $24.79 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134972625 | CMS |
| Lilly USA, LLC | $18.25 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134965375 | CMS |
| Novartis Pharmaceuticals Corporation | $18.26 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087007934 | CMS |
| Novartis Pharmaceuticals Corporation | $16.29 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087007944 | CMS |
| PFIZER INC. | $21.30 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131536940 | CMS |
| PFIZER INC. | $14.32 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131505091 | CMS |
| Radius Health, Inc. | $21.89 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089950157 | CMS |
| Radius Health, Inc. | $27.35 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089950161 | CMS |
| UCB, Inc. | $21.90 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143056570 | CMS |
| UCB, Inc. | $30.14 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143056572 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.